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Abstract
Background: Orthostatic tremor (OT) remains among the most intriguing and poorly understood of movement disorders. Compared to Parkinson’s disease or
even essential tremor, there are very few articles addressing more basic science issues. In this review, we will discuss the findings of main case series on OT, including
data on etiology, pathophysiology, diagnostic approach, treatment strategies, and outcome.
Methods: Data for this review were identified by searching PUBMED (January 1966 to August 2016) for the terms ‘‘orthostatic tremor’’ or ‘‘shaky leg syndrome,’’
which yielded 219 entries. We did not exclude papers on the basis of language, country, or publication date. The electronic database searches were supplemented by
articles in the authors’ files that pertained to this topic.
Results: Owing to its rarity, the current understanding of OT is limited and is mostly based on small case series or case reports. Despite this, a growing body of
evidence indicates that OT might be a progressive condition that is clinically heterogeneous (primary vs. secondary cases) with a broader spectrum of clinical
features, mainly cerebellar signs, and possible cognitive impairment and personality disturbances. Along with this, advanced neuroimaging techniques are now
demonstrating distinct anatomical and functional changes, some of which are consistent with neuronal loss.
Discussion: OT might be a family of diseases, unified by the presence of leg tremor, but further characterized by etiological and clinical heterogeneity. More work
is needed to understand the pathogenesis of this condition.
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Introduction
The term ‘‘orthostatic tremor’’ (OT), also known as ‘‘shaky legs
syndrome’’1 was first coined in 1984 by Heilman,2 although the earlier
descriptions of this entity date back to 1970 when Pazzaglia et al.3
reported on three patients with a peculiar disorder only occurring on
standing.
This is an intriguing and rare condition, characterized by
unsteadiness when standing that is relieved when sitting or walking;
it is confirmed on neurophysiological recording by the presence of a
fast tremor of 13–18 Hz in the legs, trunk, and, sometimes, the arms,
which is coherent in all muscles studied.4 OT can be idiopathic or
secondary.5–7 Gerschlager et al.5 suggested the subdivision of OT into
two broad groups—those with primary (idiopathic) OT with or without
postural arm tremor, and those with ‘‘OT plus,’’ in whom there are
additional associated movement disorders, mainly parkinsonism.
Compared to Parkinson’s disease or even essential tremor, there are
very few articles addressing more basic science issues (e.g. laboratory
studies included gene discovery, molecular biology, and cellular
biology) and neuroimaging studies. Scientific understanding of OT is
in its infancy. In this review, we will discuss the findings of series on
OT, including data on etiology, diagnostic approach, treatment
strategies, and outcome of this challenging condition.
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Methods
Data for this review were identified by searching PUBMED
(January 1966-August 2016) for the terms ‘‘orthostatic tremor’’ or
‘‘shaky leg syndrome,’’ which yielded 219 entries. We did not exclude
papers on the basis of language, country, or publication date. The
electronic database searches were supplemented by articles in the
authors’ files pertaining to this topic.
Epidemiology
Prevalence, incidence, and mortality rates
As there are no published population-based epidemiological data,
the prevalence and incidence of OT are unknown; however, it is
considered to be a very rare entity. In the Neurological Disorders of
Central Spain (NEDICES) study,8 our group detected one OT
patient in a cohort of approximately 4,000 elderly subjects (data not
published).
Mortality in OT has not yet been studied, although with the
presence in some patients of functional disability,6,9 gait involvement,
and higher likelihood of falls,10 mainly in those with lower-frequency
tremor discharges,11 and possible cognitive impairment,12 it is con-
ceivable that OT might influence the risk of mortality.
Risk and etiological factors
Although most patients first develop OT around 60 years of age, the
age range at onset is wide, from 13 to 85 years.5,9,10,13 Adolescent or
pediatric OT cases have rarely been reported.10 Hence, given the few
cases published in the literature, it is not possible to compare the
typical (e.g. late onset) vs. early onset courses of disease. Age at onset
may differ depending on whether OT is primary or associated with
other neurologic features.5 In one classic clinical case series including
41 subjects, age at onset was significantly earlier in primary OT
(50.4¡15.1 years ) than in the OT with associated neurologic features
group (61.8¡6.4 years, p50.006).5 A review of published case series
indicates that OT is a disorder predominantly affecting female
seniors.5,9,10,13
The vast majority of cases of OT appear to be sporadic; however, a
few examples of familial cases in monozygotic twins,14 siblings,15–17 or
in a mother and her son13 have been published. In the largest clinical
series of the literature (184 patients), Hassan et al.,10 reported that
family history of OT was noted in 4.9%. Furthermore, there may be a
family history of Parkinson’s disease or other types of tremor.13 In a
recent series of 45 OT patients, a family history of any tremor was
noted in 51% patients.18 Of interest, a family history of OT was
reported in 7% patients.18
Molecular defects have not been systematically studied in OT.
There is a single study that has identified a C10orf2 Twinkle mutation
in a man with OT in his late sixties and progressive external ophthal-
moplegia.19 Twinkle is a nuclear-encoded human mitochondrial DNA
helicase.19 This observation raises the question of a possible role of
mitochondrial dysfunction in the genesis of OT.19 There is another
report of a 63-year-old female with OT carrying a REEP1 mutation
(formerly SPG31), which is almost exclusively associated with a pure
hereditary spastic paraparesis phenotype.20 The key question remains
whether the OT seen here is part of SPG31 or is coincidental.20 Given
that these two disorders are very rare, their co-occurrence by chance
would be very unlikely.20
Most cases of OT are idiopathic, with normal brain neuroimaging,
normal laboratory work-up, and no evidence of other associated
conditions.10 There are however some rare examples of structural
causes of OT or associated conditions after an extensive laboratory
and neuroimaging work-up (Table 1). Although all of these patients
presented with clinical features for OT (unsteadiness when standing
that is relieved when sitting or walking), a number of them did not
actually have typical high-frequency electromyography (EMG) dis-
charges (13–18 Hz) (Table 1). Secondary (symptomatic) cases have
been described in patients with non-tumoral aqueduct stenosis,21
relapsing polyradiculoneuropathy,21 head trauma,22 pontine and
midbrain lesions,23,24 cerebellar degeneration,25–27 spinal cord
lesion,28 paraneoplastic syndrome associated with small cell lung
cancer,29 stiff-person syndrome,30 multiple sclerosis,31 Graves’ dis-
ease,32–34 biclonal immunoglobulin (Ig)G and IgA lambda gammo-
pathy of undetermined significance,35 thiamine deficiency,36 vitamin
B12 deficiency,1 and secondary to recreational use of solvents.37 Of
interest is the description of four patients who developed reversible OT
after exposure to dopamine-blocking drugs.38
Phenomenology and clinical features
General characteristics
OT patients usually report a feeling of unsteadiness during stance
without problems when sitting and lying.4 However, they rarely report
tremor sensation or leg pain as a presenting symptom.5,13 Many
patients try to reduce the feeling of unsteadiness by standing with a
widened stance and clawing the floor with their toes.39 The onset and
cessation of the symptoms depend on the severity of the disease. On
occasion, it may start suddenly with position changes, from sitting
to standing and vice versa.13 Other patients with milder OT may
have to stand still for several minutes in order for the symptoms to
appear.5,13,40 It is characteristic that the symptoms of OT decrease
markedly on sitting, walking, or when leaning against a wall.5,13,40 The
need to sit down or to walk can be so disturbing that patients express
that they tend to avoid situations in which they have to stand still for a
long period, such as taking a shower, waiting in line, or standing at a
kitchen counter to prepare a meal.5,13,40 In fact, in these situations, the
patients usually try to alternate weight from one leg to the other, walk
in place, or lean on an object such as a chair or a countertop.40 In
more advanced stages, patients may demonstrate abnormalities in
tandem gait; these abnormalities are indistinguishable from those seen
in patients with cerebellar diseases.40
Progression of OT has been described. In most of the OT patients
followed by Gerschlager et al.,5 the symptom severity was relatively
unchanged over time, but in six of their 41 patients there was a clear
progression of symptom severity with time, as measured by the amount
of time they could stand still. In four of these, a clear spread of tremor
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Table 1. Clinical Characteristics of Published Symptomatic Orthostatic Tremor Cases
Conditions Frequency (Hz) Other Systemic or Neurological
Features
Evolution
Non-tumoral aqueduct stenosis21 6–7 Bradykinesia, rigidity, and postural





6–7 Dysesthesias and mild weakness of
the limbs, and postural tremor of
upper limbs
Remission with prednisone
Head trauma22 14–15 – No improvement
Pontine lesions23
Cavernoma 7–8 Face and arm paresthesia Partial recovery
Tuberculoma 14–15 Fever, headache, left predominate
postural tremor of the arms
Complete remission
Midbrain lesion24 16 Truncal and cranial muscles
involvement
Partial recovery
Cerebellar degeneration25 14–15 Scanning speech, intention tremor,
ataxic gait
–
Cerebellar degeneration26 Gaze-evoked nystagmus, dysmetria
of saccades, scanning speech,
intention tremor in 4 limbs, and
broad-based ataxic gait
Patient 1 14 Slightly improvement with
clonazepam
Patient 2 15 No improvement
Patient 3 14 No improvement
Cerebellar degeneration27
Patient 1 13.8–15.9 Dysmetria, ataxic gait, cognitive
impairment, and nystagmus
No improvement
Spinocerebellar ataxia type 2 13 Dysarthria, dysmetria, ataxic gait,




Spinal cord lesion,28 12–13 Cognitive impairment, voiding
difficulty, and postural instability
Complete remission after
spinal schwannoma




Patient 1 – Stiffness and spasms Improvement with
Patient 2 16 Stiffness and spasms clonazepam
Multiple sclerosis31 4 Dysmetria, ataxia, pyramidal signs
and sensorial deficits
No improvement
Graves’ disease32 14–16 – Complete remission after
carbimazole
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was confirmed, with tremor initially only involving the leg muscles and
then spreading proximally to involve the trunk and arm muscles.5 By
contrast, in a recent series of 68 OT patients, a total 79.4% of patients
reported worsening of their OT tremor symptoms.9 These patients had
significantly longer symptom duration than those without reported
worsening (median 15.5 vs. 10.5 years, respectively; p50.005).9
However, there was no change in OT frequency over time.9 In
another recent series, in 11 out of 30 cases, OT was reported to be
worse over a 54.4-month follow-up period.18 However, in the previous
studies,5,9,18 the progression of symptoms had been described by
clinical impression and information from the patients. Feil et al.,41
examined 15 patients with primary OT from a clinical cohort over
time using serial posturographic measurements.41 Posturographic data
(5.4¡4.0 years) revealed a significant increase in the total sway path
(standing on firm ground with eyes open) from 2.4¡1.3 to 3.4¡1.4
meter/minute (p50.022) and of the total root mean square values
from 9.8¡4.3 to 12.4¡4.8 mm (p50.028).41 Using objective
measurements, this long-term follow-up study indicates that primary
OT is a progressive disorder.41
Apart from in the legs, tremor is often present in other areas such as
the hands, cranial muscles, and even the trunk.13,42 In fact, only a
small proportion of patients have isolated leg tremors.13 Patients with
primary (idiopathic) OT may be divided into those with vs. those
without a postural arm tremor.5 The postural tremor is similar to
that observed in essential tremor patients.5 Indeed, the tremor
becomes obvious when the patient maintains their arms outstretched
against gravity in front of their body (e.g. extending the upper limbs
horizontally) and typically has a frequency of 5–10 Hz, which overlaps
with the frequency seen in essential tremor patients.13 Most OT
patients have such postural tremor, with the proportion ranging from
77.4% to 92.3%.5,13,18
There have been a few reports of patients whose OT was associated
with other movement disorders, mainly parkinsonism and specifically
Parkinson’s disease.5,6 Of the 41 patients included in the clinical series
by Gerschlager et al.,5 other additional neurological features were
evident in 10. Specifically, six had parkinsonism (four had typical
Parkinson’s disease, one vascular parkinsonism and restless leg
syndrome, and one had drug-induced parkinsonism). Of the remaining
four patients, two also had restless leg syndrome, one had tardive
dyskinesia of uncertain etiology, and one had orofacial dyskinesias of
uncertain etiology.5 In another clinical series, the associated move-
ment disorders were Parkinson’s disease (n51), parkinsonism (n51),
Table 1. Continued
Conditions Frequency (Hz) Other Systemic or Neurological
Features
Evolution
Graves’ disease33 8-9 – Complete remission after
methimazole
Graves’ disease34 8 Intolerance of heat, excessive
sweating and recent loss of weight




Biclonal IgG and IgA lambda
gammopathy of undetermined
significance,35
17.5 – Improvement with
gabapentin
Thiamine deficiency36 – Diplopia, gait difficulty Slow improvement
Vitamin B12 deficiency1 15 Impaired sensation of pain and heat
in a stocking distribution
Complete remission after
vitamin B12 and clonazepam
Secondary to recreational use of
solvents.37
15 – Improvement with
clonazepam
Secondary to dopamine blocking
drugs38
Metoclopramide 5–6 Mild rigidity Improvement
Sulpiride and thyethylperazine 6–7 Resting tremor Complete remission
Sulpiride 15 – Complete remission
Sulpiride 14 Vertigo and nystagmus Complete remission
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progressive supranuclear palsy (n51), restless leg syndrome (n51),
multifocal action tremor (n52), pathological proven dementia with
Lewy bodies (n51), and focal dystonia of the arm (n51).6 Further, a
few OT patients may develop incident Parkinson’s disease 5,9,43 or
progressive supranuclear palsy months or years later.44 Similarly, OT
may appear in long-standing Parkinson’s disease after 10 years.45,46
Clinical examination
From the first descriptions, OT has been reported to appear on
standing, is associated with a profound and disabling sense of
unsteadiness, and is relieved by sitting, walking or the use of a
support.2,5 It is generally accepted that classic OT manifests with a
high-frequency tremor (13–18 Hz), which means it may not be visible
on routine examination,5,13,40 and this may make the diagnosis
challenging. When patients complain that they feel unsteady on their
feet, clinicians may overlook the possibility of OT, and may focus on
other causes of unsteadiness. The examination reveals a rapid tremor
of the legs on standing, which may sometimes be palpable as a fine-
amplitude rippling of leg muscles (e.g. the gastrocnemius or quadriceps
muscles) with an associated knee tremor; the tremor may be more
easily felt than seen because of its high frequency.47 Auscultation using
a stethoscope of the gastrocnemius muscles can sometimes reveal a
characteristic of barely audible noise akin to the sound of distant rotor
blades of a helicopter.48
Neurophysiologic characteristics
The diagnosis of OT is based on history and physical examination.4
However, the diagnosis should be confirmed by surface EMG
recordings revealing on standing rhythmic activation of lower limb
muscles at sharply peaked frequencies between 13 and 18 Hz, and
sometimes higher (Figure 1).4,39 This rhythmic activity disappears
when the patient is seated or lifted off the ground. Another feature is
that these brief, highly rhythmic discharges demonstrate high
intermuscular coherence.39 These singular neurophysiologic charac-
teristics are part of the criteria established by the Movement Disorders
Society (Table 2).4
Arriving at the correct diagnosis is dependent on the medical history
and detailed clinical and EMG investigations. The definition of OT
Figure 1. Typical high-frequency electromyography discharges in orthostatic tremor. Surface electromyography recordings of a 57-year-old female
orthostatic tremor patient from left leg muscles showing discharges at the frequency of 16–18 Hz with the patient standing.
Table 2. Consensus Statement on Tremor by the Movement Disorder Society. Criteria for Orthostatic Tremor
Orthostatic tremor is a unique tremor syndrome characterized by:
1. A subjective feeling of unsteadiness during stance but only in severe cases during gait; patients rarely fall. None of the patients
have problems when sitting and lying.
2. Sparse clinical findings that are mostly limited to a visible and occasionally, only palpable fine amplitude rippling of the leg
(quadriceps or gastrocnemius) muscles when standing.
3. The diagnosis that can be confirmed only by electromyography recordings (e.g. from the quadriceps muscle) with a typical
13–18 Hz pattern. All of the leg, trunk, and even arm muscles can show this tremor, which is typically absent during tonic
activation while the patient is sitting and lying.
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states that the tremor frequency should be confirmed by EMG;
however, in practice, an accelerometer is an acceptable alternative in
cases with typical symptoms.39 Further, an electrocardiogram recorded
in the standing position could also be a simple non-invasive tool to
screen for or to support the clinical diagnosis of OT. In this sense,
Littmann49 reported a patient with OT in whom telemetry strips while
standing revealed continuous gross 13–18 Hz of oscillatory artifact,
identical to the frequency range of oscillations recorded with EMG
recordings from the thigh muscles in OT patients.
Laboratory and neuroimaging work-up
Currently, there are no laboratory findings that are typical of OT.
In fact, it is considered to be an idiopathic disorder, as studies
with cerebral neuroimaging and other examinations are generally
normal. Hence, the purpose of laboratory investigations is to help
exclude other disorders or possible symptomatic (secondary) cases.
In specific patients, screening investigations should include thyroid
function tests, serum protein electrophoresis to rule out gammopathies,
vitamin B12 levels, diagnostic studies to exclude Wilson’s disease
(e.g. serum ceruloplasmin), and dopamine transporter imaging to rule
out Parkinson’s disease. Brain MRI should be performed to rule out
structural causes of OT such as pontine (Figure 2) and midbrain lesions
or cerebellar atrophy. In some cases with bilateral pyramidal tract
signs, or with a sensory level, spinal MRI could be useful to detect
spinal cord lesions.28
Differential diagnosis
OT is not widely recognized by physicians who are not movement
disorders experts, which often results in misdiagnosis for the
unfortunate patients, who then may be subjected to inappropriate or
unnecessary tests and treatment. In fact, it is often misdiagnosed as
essential tremor, Parkinson’s disease, restless leg syndrome, lumbar
stenosis, and especially non-organic (psychogenic) balance disor-
ders.5,13,50 Of note, when Pazzaglia et al.3 saw the first of their three
patients in January 1968 they were left perplexed and puzzled and
doubted its true organic nature.
A lack of recognition may lead to misdiagnosis; the fact that the key
physical signs are subtle and easily missed can further contribute to
that misdiagnosis.5,13 Indeed, in the series by Gerschlager et al,5 5.7
years elapsed between reported symptom onset and diagnosis. In
another series, the duration of symptoms prior to diagnosis of OT was
6.7 years.18 Finally, the series by Hassan et al.10 reported that diagnosis
was delayed by a mean of 7.2 years.
The differential diagnosis includes a number of conditions that are
characterized by unsteadiness or tremor while standing. As a similar
tremor can be induced in normal persons via vestibular stimulation,51
conditions that cause imbalance should be also considered.
There is an intense debate whether OT is a distinct condition or a
variant of essential tremor. Although tremor of the legs may occur in
essential tremor, it always occurs with upper limb tremor, and at
frequencies below 12 Hz, unlike OT.52,53 The main reason to consider
the link between both diseases is that a sizable number of OT patients
have a 5–10 Hz postural arm tremor,18 although only a few of them
have a family history of essential tremor;13 however, those lower-
frequency arm oscillations in OT may represent a subharmonic of the
higher-frequency tremors typical of OT, spreading throughout the
body.54 As we have commented above, the tremor of OT has two
singular features. First, its high frequency (13–18 Hz) and, second, its
high coherence values between homologous muscles of the two legs
(e.g. the left and right gastrocnemius).39 These findings differ from
those of essential tremor, in which tremor typically has a lower
frequency (4–12 Hz) and in which there are lower coherence values
between homologous muscles of the right and left side.39,52,53 Further,
ethanol intake has little efficacy in OT patients,5,13,55 unlike essential
tremor, in which the tremor improves in a large proportion of
patients.52,53 Finally, in contrast to the tremor of essential tremor, OT
shows little or no response to propanolol.5,13,56
Orthostatic myoclonus is a disorder that was first reported in 2007
in 15 elderly subjects.57 This condition is characterized by unsteadiness
during orthostatism and/or during gait and short duration myoclonic
Figure 2. Symptomatic orthostatic tremor caused by a lesion in
the posterior fossa. T1-weighted axial magnetic resonance imaging
scan showing a lesion involving the right pontine region, compatible with
a cavernoma. Case 1 from Benito-Leo´n J, Rodrı´guez J, Ortı´-Pareja M,
et al. Symptomatic orthostatic tremor in pontine lesions. Neurology
1997;49:1439–1441. Reprinted with permission from Wolters Kluwer Health.
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bursts that occurred predominately with the assumption of an upright
posture.57 EMG surface recording is essential for the diagnosis of this
entity.57 Unlike OT, the bursts are shorter in duration, non-rhythmic,
and irregular.57 Seven of these patients had a neurodegenerative
disorder and two had a systemic illness known to be associated with
myoclonus.57 In the remaining six patients, no known neurological
disorder contributed to the phenomenon. Leu-Semenescu et al.46
also described this syndrome in three Parkinson’s disease patients
complaining of unsteadiness on standing. Orthostatic myoclonus
may be underdiagnosed and can be considered a possible cause of
unsteadiness in subjects with neurodegenerative diseases. In a recent
study involving 93 subjects who were referred to a clinical neuro-
physiology unit in Pamplona (Spain) for investigation of abnormal
movements in orthostatism as a possible cause of their unsteadiness
and/or gait impairment, from January 2007 to September 2011,
orthostatic myoclonus was the most frequent disorder (17.2%),
followed by OT (13.9%) and low-frequency tremors during orthostat-
ism (12.9%).58 Eleven out of 16 patients (68.7%) with orthostatic
myoclonus had an associated neurodegenerative disease, such as
multiple system atrophy (n53) Parkinson’s disease (n52), Alzheimer’s
disease (n52), mild cognitive impairment (n52), and normal pressure
hydrocephalus (n52).58
In Parkinson’s disease, low-frequency (4–6 Hz) leg tremor is rarely
seen while patients are standing.46,59 Overall, the response of this type
of tremor to dopaminergic drugs is good.46,59 Thomas et al.60 reported
four patients with a disabling standing tremor that appeared years
before parkinsonian symptoms were evidenced. The tremor, whose
main frequency was 6.2–6.9 Hz, with sporadic subharmonics at 8–18
Hz, was refractory to gabapentin and dramatically responded to
levodopa administration.60 The authors suggested the term ‘‘pseudo-
orthostatic tremor’’ to define this levodopa-responsive, 6–7 Hz stand-
ing tremor preceding a parkinsonian syndrome.60
What are the most significant emerging milestones that could be
expanding the clinical spectrum of OT?
The three major clinical findings that could be expanding the
clinical spectrum of OT are as follows.
First, from the first descriptions,61 a number of patients initially
reported as clinical OT (based on the subjective feeling of unsteadiness
on standing) did not actually have typical high-frequency EMG
discharges (13–18 Hz).11 These patients reported as ‘‘slow OT’’ do
have 70–120 ms EMG bursts at lower frequencies (,13 Hz).11 In slow
OT, EMG coherence analysis reveals significant bilateral coupling at
tremor frequency between EMG recorded from lower limb, upper
Figure 3. Resting state functional MRI findings in orthostatic tremor. Resting state brain networks showing significant functional connectivity differences
between a series of 13 orthostatic tremor patients vs. 13 matched healthy controls.
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limb, and axial muscles (coherence 0.2–0.8), which is absent in controls
under normal conditions, and patients with orthostatic myoclonus, and
is not as strong as that seen in fast OT (coherence 0.8–1).62 In addition
to idiopathic cases,63,64 slow OT has been associated with familial
essential tremor,61 multiple sclerosis,31 Graves’ disease,33 Parkinson’s
disease and parkinsonism.65 Slow OT would seem to represent a
different clinical entity from classic fast OT with more heterogeneous
clinical and neurophysiologic features. It would be a summary of many
conditions and presentations resembling ‘‘classical OT,’’ many of
which present with sub-harmonic peaks of an actual ‘‘fast’’/classical
OT (see, for example, EMG traces of the first report of slow OT in
Wee et al.,61 where the EMG in figure 2 actually exhibits a 16 Hz
pattern), or non-rhythmical presentations, which are unlikely ‘‘tremor’’
(orthostatic myoclonus?) and would therefore speak against an
inclusion into an ‘‘expanded’’ spectrum of OT.
Second, accumulating evidence suggests that OT is a disease of the
cerebellar and/or cerebellar system. For example, in a recent clinical
series of 18 OT patients, careful clinical examination revealed that at
least mild cerebellar ocular motor dysfunction such as saccadic smooth
pursuit was found in all the patients with most of them also showing
different forms of nystagmus and with 14 out of 18 showing additional
ataxia of at least one limb.41 This is in line with a recent multimodal
neuroimaging study involving 17 OT patients and 17 age- and gender-
matched healthy volunteers, which has demonstrated functional
relevance of cerebello-thalamo-cortical connections in tremor related
to cerebellar defects.66 Specifically, compared with healthy volunteers,
gray matter volume in OT patients was 1) increased in the cerebellar
vermis and correlated positively with the duration of the standing
position; and 2) increased in the supplementary motor area and
decreased in the lateral cerebellum, which both correlated with the
disease duration.66 Further, functional connectivity between the lateral
cerebellum and the supplementary motor area was abnormally
increased in OT patients, and correlated positively with tremor
severity.66 Of interest was that after repetitive transcranial stimulation,
tremor severity and functional connectivity between the lateral
cerebellum and the supplementary motor area were reduced.66
Finally, the link between OT and the cerebellum is of interest,
especially in light of the role the cerebellum plays in cognition,67 and it
raises the possibility that OT patients could have cognitive deficits
consistent with cerebellar dysfunction. Cognitive function in OT has
been the subject of a recent case–control comparison.12 Sixteen OT
patients scored worse than 32 healthy matched controls on widespread
cognitive domains, including deficits in executive function, visuospatial
ability, verbal memory, visual memory, and language.12 Further, OT
patients scored higher (i.e. greater psychopathology) on several
personality assessment inventory subscales (somatic concerns, anxiety
related disorders, depression, and antisocial features).12 Indeed, OT
patients seem to have deficits in specific aspects of neuropsychological
functioning, particularly those thought to rely on the integrity of the
prefrontal cortex, which suggests involvement of frontocerebellar
circuits.12 The question is whether these cognitive impairment and
personality disturbances may be non-motor manifestations of OT.
These results were supported by a recent functional MRI study
comparing resting-state functional connectivity in OT patients and
healthy controls, and specifically assessing cognitive processing
networks.68 Overall, relative to healthy controls, OT patients increased
connectivity in resting-state networks involved in cognitive processes
(default mode network, as well as in executive and frontoparietal
networks), and decreased connectivity in motor control (cerebellum
and sensorimotor networks) (Figure 3).68 Changes in network integrity
were associated not only with duration (default mode network and
visual network), but also with cognitive function.68 Moreover, in at
Figure 4. T1-weighted sagittal magnetic resonance image showing the region of interest (cerebellar vermis) for the proton magnetic
resonance spectroscopy study by Benito-Leo´n et al.92 The labeled resonances are those of N-acetylaspartate+N-acetylaspartyl glutamate (NAA), total
creatine (CR) and total choline-containing compounds (CHO). The spectra are plotted on the same vertical intensity scale normalized to background noise.
ppm, Parts Per Million. Note the reduced NAA resonance in a 61-year-old female orthostatic tremor patient (C) compared to that from a matched healthy
subject (B), whereas there is a minor decrease in either CHO or CR.
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least two networks (default mode network and visual network),
increased connectivity was associated with worse performance on
different cognitive domains (attention, executive function, visuospatial
ability, visual memory, and language).68 Resting-state functional MRI
studies might provide a novel method to understand the pathophy-
siological mechanisms of motor and non-motor features of OT.
Severity assessment of orthostatic tremor
There is not a validated tool to measure severity of symptoms and
disability related to OT. Hence, there is a need for instruments to
monitor OT clinically. What is indisputable is that OT may be a
progressing and disabling condition that may negatively impact on
different spheres of the health-related quality of life of those who suffer
this condition, including occupational and daily living activities, as the
patients tend to avoid situations where they have to stand still.39 There
is nowadays increasing recognition that the global wellbeing of patients
with chronic neurological diseases is an important outcome in research
and clinical practice alike.69–71 Subjective (i.e. self-reported) measures
of health-related quality of life may serve to alert clinicians to areas
that would otherwise be overlooked.69–71 There are only two studies
that have studied specifically health-related quality of life in OT.72,73
Gerschlager et al.72 applied the SF-36 and the Beck Depression
Inventory to measure health-related quality of life and depression,
respectively, in 20 OT patients. All dimensions of the SF-36 were
markedly reduced in OT patients and depression was found in 11 out
of 20 patients.72 Rodrigues et al.,73 using a modified Parkinson’s
disease questionnaire (PDQ-39), observed in five OT patients that
mobility, activities of daily living, bodily discomfort, emotional
wellbeing, and cognition dimensions were domains that were affected
in patients with OT, and these problems improved slightly with
gabapentin. Overall, these two studies suggest that OT strongly
impacts on health-related quality of life.
Pathophysiology
OT might be generated by a central oscillator
The traditional hypothesis about pathogenesis of OT posits the
existence of a central oscillator mostly located in the brainstem and/or
the cerebellum.74–76 The hypothesis that OT is generated in these
areas is based on several observations. First, a small number of
symptomatic OT cases have cerebellar atrophy or have lesions in the
pons or midbrain.23–27 Second, one positron emission tomography
study of four OT patients revealed bilateral activation of the cerebellar
hemispheres as well as activation of the cerebellar vermis, thalamus,
and lentiform nucleus.77 Third, posturographic data from some OT
patients are indistinguishable from those seen in patients with
cerebellar diseases.41 Fourth, most patients had cerebellar signs on
detailed clinical examination.41 Fifth, a recent multimodal neuroima-
ging study has demonstrated functional relevance of cerebello-
thalamo-cortical connections in tremor related to cerebellar defects.66
Sixth, cerebellar outflow (dentato-rubro-thalamic) pathways are the
target of deep brain stimulation, which may be effective in treating
OT.10,78–84 Finally, the tremors recorded in each leg have a high
coherence. In other words, they have an almost constant phase
relationship, which is not typical for most other pathological tremors.39
These findings suggest that the OTs detected in each leg originate
from the same central tremor generator.85 In addition, 16 Hz EMG
bursts are time-locked in the arm, leg, truncal, and even facial muscles,
and are bilateral.54 Finally, the observation that unilateral transcranial
magnetic stimulation of the cortical leg area resets OT in both legs,
whereas OT is not modified by any peripheral stimuli, supports the
hypothesis of a unique supraspinal OT generator.75 The circuitry
involving in OT pathogenesis, however, may be complex, with
feedback and feed forward modulation (i.e. involving several brain
regions).13 There is some evidence of a potential role of the
nigrostriatal dopaminergic system in the generation of OT. An
association of OT with parkinsonism and treatment effects of levodopa
and dopamine agonists have been reported.5,43,86,87 By means of
single-photon emission computed tomography (SPECT) using 123I-
FP-CIT ([123I]-2b-carbomethoxy-3b-(-4-iodophenyl)-N-(3-fluoropropyl)-
nortropane) as dopamine transporter tracer, the dopaminergic system
was found to be affected in a group of 11 OT patients, although to a
lesser extent than in Parkinson’s disease.87 When compared with a
group of 12 Parkinson’s disease patients, tracer uptake in OT patients
was significantly higher and more symmetrical, and the caudates and
putamens were equally affected.87 A study using transcranial sono-
graphy to examine the morphology of the substantia nigra in four OT
patients showed echogenicity in all of them (unilateral in three
and bilateral in one patient), suggesting the presence of nigrostriatal
dopaminergic deficits.88 However, these findings are not universal, and
other functional imaging studies have shown intact serotonergic and
dopaminergic systems.89–91 Taken together, these findings suggest that,
although the OT generator might be located in the brainstem and/or
the cerebellum, other brain regions such as the motor and sensory
cortices, and the basal ganglia may also be involved.76
OT may be neurodegenerative
OT shares a number of important features with neurodegenerative
diseases. First, OT is a progressive disorder with increasing disability,
suggesting that the underlying pathological process may not be
static.6,9 Second, patients who initially present with isolated OT often
later develop additional neurological signs, including Parkinson’s
disease.5,9,43 Third, a reduction in cerebral cortical and cerebel-
lar cortical viability in OT has been recently published.92 Using
proton magnetic resonance spectroscopy in a sample of 14 OT
patients vs. 14 matched healthy controls, in mid-parietal gray matter
spectra, a significant decrease in the absolute concentration of
N-acetylaspartate+N-acetylaspartyl (NAA) glutamate in the patients
vs. the controls (7.76¡0.25 vs. 8.11¡0.45, p50.017) was observed.92
A similar decrease in NAA was seen in the cerebellar vermis
(7.33¡0.61 vs. 8.55¡1.54, p50.014) and cerebellar white matter
(8.54¡0.79 vs. 9.95¡1.57, p50.010) of the cerebellum (Figure 4).92
No differences in the other metabolites or their ratios were observed.92
Fourth, as in other neurodegenerative diseases93,94 cognitive deficits,
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mainly in frontal executive function and memory, have been reported
to occur in OT patients.12
The conceptualization of OT as a neurodegenerative condition has
some clinical implications. It indicates that there is a cellular and
molecular pathophysiology of OT and the disease is not merely the
result of an electrical disarrangement. Another implication is that,
moving forward, this makes the identification of modifiable risk factors
more important, along with strategies aimed at disease prevention. In
addition, future drug development could target important molecular
and cellular events in the degenerative cascade.
Treatment
General considerations
As with other chronic diseases, physicians should pay attention to
the psychological and social impact of illness on OT patients. Further,
the impact of the disease on the patient’s family should also be
considered. It may be beneficial for OT patients to bring their spouse
or partner to a consultation, to help them better understand the disease
and to discuss their difficulties and concerns.
Patient-centered associations may be of help in offering individual
and group support, education and advice (http://www.
orthostatictremor.org/). Through such interactions, patients may
benefit by learning ways to cope with the many practical day-to-day
difficulties that arise for those living with this disease (http://www.
orthostatictremor.org/).
There are physical aids and certain lifestyle changes that may be
helpful in patients with mild OT. Physical aids may offer some sympto-
matic relief. For instance, portable stools may permit patients to sit
rather than have to stand when they are waiting in line or are at social
events. A tripod walking stick could be also helpful for this purpose.
Furthermore, weight reduction may be helpful in overweight patients.
Pharmacological agents
As a result of the rarity of this condition, there are no well-designed
randomized controlled trials. Further, overall, pharmacological agents,
which have been empirically used, have often yielded insufficient
benefit. Table 3 shows the dosage, clinical efficacy, and practical
comments about the different pharmacological agents that have been
used to treat OT. Such treatments have side effects, and it is important
to carefully consider in each patient whether the benefits outweigh any
side effects. As a general rule, treatment should be initiated when the
tremor begins to interfere with the patient’s ability to perform daily
activities. Surgery may be the final option for a select group of patients
who have not responded adequately to medications.7 Unlike essential
tremor, OT does not improve either with alcohol or propranolol.40,56
Of all the medications, clonazepam is probably the first-line
medication in the treatment of primary and secondary OT.5,10,23,39
Table 3. Pharmacological Agents to Treat Orthostatic Tremor
Medication Dosage Clinical Efficacy Comment
Clonazepam 0.5–6 mg/day +++ Documented effect
Gabapentin 300–2400 mg/day ++ Documented effect
Levodopa 300–800 mg/day ++ Only short-term benefit
Pramipexole 0.75 mg/day + Anecdotal effect
Primidone 125–250 mg/day + Anecdotal effect
Valproic acid 500–1000 mg/day +/– Anecdotal effect
Carbamazepine 400 mg/day +/– Anecdotal effect
Phenobarbital 100 mg/day +/– Anecdotal effect
Intravenous
immunoglobulin1
2 g/kg over 3 days + Anecdotal effect
Propanolol 120 mg/day – Without effect
Levetiracetam 3000 mg/day – Without effect
Botulinum toxin 200 mU in the tibialis anterior
bilaterally
– Without effect
Alcohol – – Without effect
1It was used in a case of slow orthostatic tremor associated with a novel antineuronal antibody.103
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This drug reduces tremors in about one-third of people who have the
disorder. In some patients, it eliminates tremor almost entirely.95
Clonazepam is typically started at 0.5 mg daily, preferably at night,
and, if tolerated, gradually titrated upwards to 2 mg three times a day.
However, it is not clear whether this benefit is sustained over
time.5,13,55,63,96,97
Second-line therapies, either as monotherapy or in combination,
include gabapentin in doses ranging from 300 to 2,400 mg/day,73,98–
100 and others with variable benefit, such as primidone,85,96,101 sodium
valproate,13 carbamazepine,5 phenobarbital,102 and intravenous
immunoglobulin.103 Dopaminergic drugs may be helpful in some
patients over a short period of time, especially those who subsequently
develop Parkinson’s disease.40 Pramipexole, a dopaminergic agonist,
was reported to be effective in a single patient with OT.86 In a series of
eight OT patients treated with levodopa, five of them experienced
benefit and elected to remain on long-term treatment.43 By contrast, a
2-month open-label trial of levodopa treatment (600 mg/day) led to a
small improvement in two of five patients but no significant overall
change and no sustained benefit.87
Finally, other medications, such as levetiracetam, are ineffective in
the treatment of OT.104 Treatment with 200 mU of botulinum toxin
in the tibialis anterior bilaterally did not alleviate either subjective
experience of unsteadiness or tremor in a small series of seven OT
patients.105
Surgical treatment
The number of OT patients who have undergone surgery to treat
their symptoms is still insufficient to make strong recommendations.
However, bilateral ventral intermediate thalamic nucleus stimulation
could provide long-lasting relief of symptoms in some patients with
medication-resistant OT.10,78–84 Nonetheless, in another patient who
was treated with unilateral deep brain stimulation of the ventral
intermediate thalamic nucleus, clinical benefits receded after
3 months.78 Alternatively, chronic spinal cord stimulation has
demonstrated a beneficial effect with long-term follow-up in a few
patients with medically intractable primary OT.106,107 Espay et al.,78
postulated that since thalamic and spinal stimulation produce similar
results in OT, perhaps a common modulatory role of the cerebello-
thalamo-cortico-spinal system may be affected at different levels of the
neural axis.
Conclusion
OT is a rare and singular movement disorder that is characterized
by tremor of the legs and trunk, and is present on standing and
improving on walking or sitting. The origin and mechanism of this
condition are not well understood; notwithstanding, most studies
suggest that it arises from an oscillator in the posterior fossa, possibly in
the brainstem and/or the cerebellum. Although OT is generally
considered to be a distinct and primarily ‘‘idiopathic’’ disorder, with
normal brain MRI and laboratory work-up, symptomatic OT cases
have been described as well.
We are now seeing the clinical expansion of the concept of
OT in recent years to include other neurological features (cerebellar
dysfunction signs) and non-motor features (cognitive problems,
psychiatric problems), the heterogeneity of pharmacological response
profiles and clinical progression, and the association of OT with
Parkinson’s disease and other types of parkinsonism. We propose that
OT might be a family of diseases, unified by the presence of leg
tremor, but further characterized by etiological and clinical hetero-
geneity. Effective pharmacological treatments for the disorder remain
limited, although new insights into disease mechanisms might result in
more-effective therapies. Along with this, advanced neuroimaging
techniques are now demonstrating distinct anatomical and functional
changes, some of which are consistent with neuronal loss, in OT
patients. However, more work is needed to understand the pathogen-
esis of this condition.
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